307 related articles for article (PubMed ID: 18818324)
1. Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.
Bogerd HP; Tallmadge RL; Oaks JL; Carpenter S; Cullen BR
J Virol; 2008 Dec; 82(23):11889-901. PubMed ID: 18818324
[TBL] [Abstract][Full Text] [Related]
2. Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.
Zielonka J; Bravo IG; Marino D; Conrad E; Perković M; Battenberg M; Cichutek K; Münk C
J Virol; 2009 Aug; 83(15):7547-59. PubMed ID: 19458006
[TBL] [Abstract][Full Text] [Related]
3. Functional domain organization of human APOBEC3G.
Gooch BD; Cullen BR
Virology; 2008 Sep; 379(1):118-24. PubMed ID: 18639915
[TBL] [Abstract][Full Text] [Related]
4. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors.
Russell RA; Wiegand HL; Moore MD; Schäfer A; McClure MO; Cullen BR
J Virol; 2005 Jul; 79(14):8724-31. PubMed ID: 15994766
[TBL] [Abstract][Full Text] [Related]
5. Recent insights into HIV-1 Vif.
Navarro F; Landau NR
Curr Opin Immunol; 2004 Aug; 16(4):477-82. PubMed ID: 15245742
[TBL] [Abstract][Full Text] [Related]
6. Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains.
Hakata Y; Landau NR
J Biol Chem; 2006 Dec; 281(48):36624-31. PubMed ID: 17020885
[TBL] [Abstract][Full Text] [Related]
7. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
Ji S; Na L; Ren H; Wang Y; Wang X
J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
[TBL] [Abstract][Full Text] [Related]
8. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.
Bogerd HP; Wiegand HL; Doehle BP; Cullen BR
Virology; 2007 Aug; 364(2):486-93. PubMed ID: 17434555
[TBL] [Abstract][Full Text] [Related]
9. Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.
Goila-Gaur R; Khan MA; Miyagi E; Kao S; Strebel K
Retrovirology; 2007 Aug; 4():61. PubMed ID: 17727729
[TBL] [Abstract][Full Text] [Related]
10. Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection.
Chen C; Li F; Montelaro RC
J Virol; 2001 Oct; 75(20):9762-70. PubMed ID: 11559809
[TBL] [Abstract][Full Text] [Related]
11. Proteomic alteration of equine monocyte-derived macrophages infected with equine infectious anemia virus.
Du C; Liu HF; Lin YZ; Wang XF; Ma J; Li YJ; Wang X; Zhou JH
Proteomics; 2015 Jun; 15(11):1843-58. PubMed ID: 25684102
[TBL] [Abstract][Full Text] [Related]
12. Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid.
Derse D; Hill SA; Princler G; Lloyd P; Heidecker G
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2915-20. PubMed ID: 17299050
[TBL] [Abstract][Full Text] [Related]
13. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication.
Li F; Chen C; Puffer BA; Montelaro RC
J Virol; 2002 Feb; 76(4):1569-77. PubMed ID: 11799151
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases.
Dutko JA; Schäfer A; Kenny AE; Cullen BR; Curcio MJ
Curr Biol; 2005 Apr; 15(7):661-6. PubMed ID: 15823539
[TBL] [Abstract][Full Text] [Related]
15. Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays.
Jin J; Sturgeon T; Chen C; Watkins SC; Weisz OA; Montelaro RC
J Virol; 2007 Oct; 81(20):11226-35. PubMed ID: 17686839
[TBL] [Abstract][Full Text] [Related]
16. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.
Tang YD; Na L; Zhu CH; Shen N; Yang F; Fu XQ; Wang YH; Fu LH; Wang JY; Lin YZ; Wang XF; Wang X; Zhou JH; Li CY
J Virol; 2014 Nov; 88(21):12296-310. PubMed ID: 25122784
[TBL] [Abstract][Full Text] [Related]
17. Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization.
Wang XF; Wang YH; Bai B; Zhang M; Chen J; Zhang X; Gao M; Wang X
J Virol; 2021 Nov; 95(23):e0108721. PubMed ID: 34495693
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.
Li J; Zhang X; Bai B; Zhang M; Ma W; Lin Y; Wang X; Wang XF
J Virol; 2022 Dec; 96(24):e0121022. PubMed ID: 36448796
[TBL] [Abstract][Full Text] [Related]
19. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses.
McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM
Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012
[TBL] [Abstract][Full Text] [Related]
20. Structure of equine infectious anemia virus proteinase complexed with an inhibitor.
Gustchina A; Kervinen J; Powell DJ; Zdanov A; Kay J; Wlodawer A
Protein Sci; 1996 Aug; 5(8):1453-65. PubMed ID: 8844837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
